Endocrinology News

Adolescents with obesity assigned the weekly GLP-1 receptor agonist exenatide for 6 months experienced a modest reduction in BMI along with improvements in several cardiometabolic markers, including 2-hour glucose and lipid profile, according to findings published in Pediatric Obesity.

Approximately 34.1 million U.S. adults — more than 1 in 10 —have type 1 or type 2 diabetes, and 7.3 million of those adults who met laboratory criteria were unaware or did not report having the disease, according to data from the CDC’s 2020 National Diabetes Statistics Report.

Children may be more likely to develop overweight or obesity if their mothers are exposed to high levels of paraben while pregnant, according to findings published in Nature Communications.

Adolescents with obesity and polycystic ovary syndrome have an altered gut microbiome compared with girls without PCOS with a similar BMI and dietary habits, according to findings from a case-control study.

Reference ranges for thyroid function among adolescents differ substantially from those for adults, according to findings from a longitudinal analysis published in The Journal of Clinical Endocrinology & Metabolism.

Researchers assessing a cohort of primarily euthyroid mother-child pairs observed positive associations between maternal and cord thyroid-stimulating hormone concentrations and maternal and early childhood TSH concentrations, according to findings published in Clinical Endocrinology.

Excess weight at age 3 years is associated with higher risk for overweight or obesity at age 15 years, according to findings published in Pediatric Obesity.

To kick off the new year, IDC has assembled a list of the 10 most-read stories of 2019. Please follow the links to access the full stories.

Obesity may affect a clinician’s ability to correctly interpret 24 routine blood tests for children, including liver function tests, inflammation markers, lipids and iron levels, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

LOS ANGELES — Liraglutide is effective in lowering HbA1c and should be considered to prevent progression to type 2 diabetes among children, according to a diabetes expert here at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.